Linscomb Wealth Inc. Sells 29 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Linscomb Wealth Inc. decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.0% in the 1st quarter, Holdings Channel reports. The fund owned 949 shares of the healthcare conglomerate’s stock after selling 29 shares during the quarter. Linscomb Wealth Inc.’s holdings in UnitedHealth Group were worth $470,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. IFG Advisory LLC lifted its holdings in UnitedHealth Group by 3.6% during the 4th quarter. IFG Advisory LLC now owns 4,345 shares of the healthcare conglomerate’s stock worth $2,288,000 after purchasing an additional 153 shares in the last quarter. Altfest L J & Co. Inc. lifted its holdings in UnitedHealth Group by 8.6% during the 4th quarter. Altfest L J & Co. Inc. now owns 4,233 shares of the healthcare conglomerate’s stock worth $2,228,000 after purchasing an additional 335 shares in the last quarter. 25 LLC purchased a new stake in UnitedHealth Group during the 4th quarter worth about $205,000. Investment Research & Advisory Group Inc. raised its holdings in shares of UnitedHealth Group by 0.7% in the 4th quarter. Investment Research & Advisory Group Inc. now owns 6,058 shares of the healthcare conglomerate’s stock valued at $3,189,000 after acquiring an additional 40 shares in the last quarter. Finally, WASHINGTON TRUST Co raised its holdings in shares of UnitedHealth Group by 23.1% in the 4th quarter. WASHINGTON TRUST Co now owns 1,465 shares of the healthcare conglomerate’s stock valued at $771,000 after acquiring an additional 275 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on UNH shares. Deutsche Bank Aktiengesellschaft raised their price target on UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a report on Friday, April 19th. Morgan Stanley raised their price target on UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. JPMorgan Chase & Co. raised their price objective on UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a report on Thursday, May 30th. HSBC raised their price objective on UnitedHealth Group from $580.00 to $610.00 in a report on Thursday, July 18th. Finally, Barclays raised their price objective on UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. One equities research analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $614.17.

UnitedHealth Group Trading Up 1.8 %

Shares of UNH stock traded up $10.04 during trading hours on Friday, reaching $569.72. The company’s stock had a trading volume of 3,202,023 shares, compared to its average volume of 5,159,030. The stock has a market capitalization of $524.36 billion, a P/E ratio of 34.82, a P/E/G ratio of 1.56 and a beta of 0.60. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $581.50. The firm’s fifty day simple moving average is $508.82 and its 200 day simple moving average is $501.45. The company has a current ratio of 0.88, a quick ratio of 0.85 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The firm had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period last year, the company earned $6.14 EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 27.68 EPS for the current year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.47%. The ex-dividend date was Monday, June 17th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Insider Activity

In other news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.